Durham, NC (PRWEB) October 06, 2015 -- Arcato Laboratories, developer of OraWaxTM, a revolutionary new treatment for the discomfort caused by orthodontic braces, has been selected to present at 1 Million Cups in Research Triangle Park on Wednesday, October 7, 2015. The presentation will be delivered by Christopher S. Meldrum, President & CEO of Arcato Laboratories.
“In the United States alone, 4 million people wear braces and most of them agree that braces are painful,” said Meldrum. “Arcato’s solution is OraWax™, a patented time-release formulation combining wax, benzocaine, and special polymers,” he added.
1 Million Cups (1MC) is a national program designed to educate, engage, and connect entrepreneurs. Developed by the Kauffman Foundation, 1MC is based on the notion that entrepreneurs discover solutions and network over a million cups of coffee. It is free to the public and will take place at 9:00 a.m. at 800 Park Office Drive, Research Triangle Park, situated between Raleigh and Durham, North Carolina.
The research related to the OraWaxTM patent was undertaken by Dr. Michael Jay, the founder of Arcato and its CSO. Dr. Jay is also the Executive Vice Dean and Fred Eshelman Distinguished Professor of biomedical engineering in the School of Pharmacy at the University of North Carolina at Chapel Hill, and is an expert on drug delivery and drug formulations.
Arcato is currently raising money to complete FDA regulatory clearance for OraWax™. The company is issuing its Series B Convertible Participating Preferred Stock, which is in turn convertible into shares of the Company’s common stock.
“Arcato is issuing securities directly to investors in the new Reg D 506(c) offering,” said Thomas Vass, the investment advisor to the company. “The common term for this type of offering is equity crowdfunding, and we are proud to be one of the first technology companies in North Carolina to undertake this type of internet-based offering,” he added.
For more information on becoming and investor, visit the Investor Relations page for this Reg D 506(c) offering.
About Arcato Laboratories
Arcato Laboratories, a leader in the sustained release of anesthetics, is commercializing proprietary products to serve specialty oral healthcare practitioners, such as orthodontists and oral surgeons. Arcato’s first product, a medical device named OraWax™, targets orthodontists and their patients as the first effective treatment for oral discomfort caused by orthodontic appliances (braces).
Contact Christopher S. Meldrum: cmeldrum(at)arcatolabs(dot)com
Company website: http://www.arcatolabs.com
Christopher S. Meldrum, Arcato Laboratories, http://investors.arcatolabs.com, +1 919-473-9296, [email protected]